$EVEX
Eve Holding, Inc. Stock $evex

$evex Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000155485522000729 Filed on December 23, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$8.964M	$6.845M	$1.328M
YoY Change	575.25%	279.07%
% of Gross Profit
Research & Development	$18.03M	$14.30M	$13.28M
YoY Change	35.75%	409.59%
% of Gross Profit
Depreciation & Amortization	$24.88K	$0.00	$107.9K
YoY Change	-76.95%
% of Gross Profit
Operating Expenses	$26.99M	$21.14M	$1.328M
YoY Change	1933.19%	1070.92%
Operating Profit		-$38.57M
YoY Change		929.84%
Interest Expense	$7.249M	$2.314M	-$2.073M
YoY Change	-449.78%	-76.44%
% of Operating Profit
Other Income/Expense, Net		$536.6K
YoY Change
Pretax Income	-$19.74M	-$36.25M	-$3.400M
YoY Change	480.61%	-552.2%
Income Tax	$312.9K	$490.4K	$0.00
% Of Pretax Income
Net Earnings	-$20.05M	-$36.74M	-$3.400M
YoY Change	489.81%	-558.32%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.14
Diluted Earnings Per Share	-$0.07	-$0.14	-$118.3K
COMMON SHARES
Basic Shares Outstanding	266.4M shares	264.3M shares
Diluted Shares Outstanding		272.0M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$227.9M	$248.3M	$475.3K
YoY Change	47850.44%	23009.93%
Cash & Equivalents	$49.15M	$77.94M	$14.38M
Short-Term Investments	$178.8M	$170.4M
Other Short-Term Assets	$1.426M	$2.974M	$21.14K
YoY Change	6643.17%	1874.95%
Inventory
Prepaid Expenses
Receivables
Other Receivables			$220.0K
Total Short-Term Assets	$312.2M	$333.1M	$14.62M
YoY Change	2035.82%	27092.49%	541.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$451.6K	$418.7K	$0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$236.9M
YoY Change
Other Assets	$0.00
YoY Change
Total Long-Term Assets	$668.2K	$418.7K	$699.8K
YoY Change	-4.51%	-99.82%	-99.7%
TOTAL ASSETS
Total Short-Term Assets	$312.2M	$333.1M	$14.62M
Total Long-Term Assets	$668.2K	$418.7K	$699.8K
Total Assets	$312.9M	$333.5M	$15.32M
YoY Change	1942.61%	41.42%	-93.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.097M	$2.963M	$877.6K
YoY Change	138.95%	-27.2%
Accrued Expenses	$2.492M		$0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$24.93M	$28.02M	$1.526M
YoY Change	1533.86%	588.35%	333.47%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.020M	$838.8K	$702.9K
YoY Change	45.12%	-96.95%
Total Long-Term Liabilities	$1.020M	$838.8K	$702.9K
YoY Change	45.12%	-96.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.93M	$28.02M	$1.526M
Total Long-Term Liabilities	$1.020M	$838.8K	$702.9K
Total Liabilities	$25.95M	$28.86M	$2.229M
YoY Change	1064.37%	-8.66%	-95.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$217.0M	-$197.0M	$0.00
YoY Change			-100.0%
Common Stock	$503.9M	$501.6M	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$286.9M	$304.7M	$13.09M
YoY Change
Total Liabilities & Shareholders Equity	$312.9M	$333.5M	$15.32M
YoY Change	1942.61%	41.42%	-93.47%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q4
OPERATING ACTIVITIES
Net Income	-$20.05M	-$36.74M	-$3.400M
YoY Change	489.81%	-558.32%
Depreciation, Depletion And Amortization	$24.88K	$0.00	$107.9K
YoY Change	-76.95%
Cash From Operating Activities	-$20.74M	-$16.96M	-$599.1K
YoY Change	3361.63%	6421.97%
INVESTING ACTIVITIES
Capital Expenditures	$57.75K	-$418.7K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$8.000M	-$96.00M	-$2.300M
YoY Change	247.83%
Cash From Investing Activities	-$8.058M	-$96.42M	-$2.300M
YoY Change	250.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	15.00M	2.300M
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	-20.74M	-16.96M	-599.1K
Cash From Investing Activities	-8.058M	-96.42M	-2.300M
Cash From Financing Activities	0.000	15.00M	2.300M
Net Change In Cash	-28.80M	-98.38M	-599.1K
YoY Change	4706.67%	37738.06%
FREE CASH FLOW
Cash From Operating Activities	-$20.74M	-$16.96M	-$599.1K
Capital Expenditures	$57.75K	-$418.7K
Free Cash Flow	-$20.80M	-$16.54M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q3	us-gaap	Short Term Investments ShortTermInvestments	170354049	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14376523	usd
CY2022Q3	us-gaap	Short Term Investments ShortTermInvestments	170354049	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14376523	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001823652
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q3	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2021Q3	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39704
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2549808
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1400 General Aviation Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Melbourne
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32935
	dei	City Area Code CityAreaCode	(321)
	dei	Local Phone Number LocalPhoneNumber	751-5050
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	266371485	shares
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	266371485	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77941371	usd
CY2022Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	205358	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	220000	usd
CY2022Q3	evex	Loans Receivable Related Parties Current LoansReceivableRelatedPartiesCurrent	81638146	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	333113402	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	418721	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2022Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	699753	usd
CY2022Q3	us-gaap	Assets Assets	333532123	usd
CY2021Q4	us-gaap	Assets Assets	21570673	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2963007	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	14394340	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	8642340	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	6982500	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	32226	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3677865	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	616156	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	28017712	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	838845	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10871284	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32226	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	304675566	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10699389	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	333532123	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21570673	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14298925	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2805955	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33830890	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6636418	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6845045	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	939106	usd
CY2021Q3	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	0	usd
	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	0	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-38568200	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3745061	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-162499131	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9902030	usd
CY2022Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	285000	usd
CY2021Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	6127500	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2028854	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3015420	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-57914	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-153356211	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9959944	usd
CY2022Q3	evex	Loans Receivable Related Parties Current LoansReceivableRelatedPartiesCurrent	81638146	usd
CY2021Q4	evex	Loans Receivable Related Parties Current LoansReceivableRelatedPartiesCurrent	0	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	2974478	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6274397	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	333113402	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	20870920	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	418721	usd
CY2022Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0	usd
CY2021Q4	us-gaap	Assets Assets	21570673	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2963007	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	877641	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	14394340	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	8642340	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	6982500	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	32226	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	616156	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	28017712	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10168363	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	838845	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	702921	usd
CY2022Q3	us-gaap	Liabilities Liabilities	28856557	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10871284	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	266371485	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	266371485	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	220000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	220000000	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	266371	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	220000	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	501363454	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	53489579	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-196954259	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-42977964	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32226	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	304675566	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6636418	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6845045	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	939106	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	23892011	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3265612	usd
CY2022Q3	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	17424230	usd
CY2021Q3	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	0	usd
	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	104776230	usd
	evex	Expense Related To Issuance Of New Warrants ExpenseRelatedToIssuanceOfNewWarrants	0	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-38568200	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3745061	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9902030	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	6127500	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2028854	usd
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-14041	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3015420	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-57914	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-36254346	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3759102	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-153356211	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9959944	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	490376	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	247010044	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	247010044	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	220000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
	us-gaap	Net Income Loss NetIncomeLoss	-9959944	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-43779	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36744722	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3801970	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-153976295	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10003723	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10699389	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-10010008	usd
CY2022Q1	evex	Increase Decrease Through Net Transfer From Parent Equity IncreaseDecreaseThroughNetTransferFromParentEquity	732776	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	746537	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-107221565	usd
CY2022Q2	evex	Increase Decrease Through Reclassification Of Public Warrants From Liability IncreaseDecreaseThroughReclassificationOfPublicWarrantsFromLiability	10580000	usd
CY2022Q2	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	87352000	usd
CY2022Q2	evex	Stock Issued During Period Value Reverse Recapitalization Net Of Fees StockIssuedDuringPeriodValueReverseRecapitalizationNetOfFees	315326717	usd
CY2022Q2	evex	Stock Issued During Period Value Restricted Stock Units And Restricted Stock Units Expense StockIssuedDuringPeriodValueRestrictedStockUnitsAndRestrictedStockUnitsExpense	1935988	usd
CY2022Q2	evex	Stock Issued During Period Value Exercise Of Warrants Held By Private Investment In Public Equity Investor StockIssuedDuringPeriodValueExerciseOfWarrantsHeldByPrivateInvestmentInPublicEquityInvestor	8000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1028182	usd
CY2022Q2	evex	Decrease Increase Through Net Distributions To Parent Equity DecreaseIncreaseThroughNetDistributionsToParentEquity	2105409	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	307650450	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-36744722	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15000000	usd
CY2022Q3	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	17424230	usd
CY2022Q3	evex	Stock Issued During Period Value Restricted Stock Units And Restricted Stock Units Expense StockIssuedDuringPeriodValueRestrictedStockUnitsAndRestrictedStockUnitsExpense	653699	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	691909	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	304675566	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1013853	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-2509424	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-51106	usd
CY2021Q1	evex	Increase Decrease Through Net Transfer From Parent Equity IncreaseDecreaseThroughNetTransferFromParentEquity	3004907	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-569476	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-3691418	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	50195	usd
CY2021Q2	evex	Increase Decrease Through Net Transfer From Parent Equity IncreaseDecreaseThroughNetTransferFromParentEquity	2283398	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-1927301	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3759102	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	490376	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	620084	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-36744722	usd
	us-gaap	Net Income Loss NetIncomeLoss	-153976295	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9959944	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	272040343	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	272040343	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	220000000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	247010044	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	247010044	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	220000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3759102	usd
	us-gaap	Net Income Loss NetIncomeLoss	-153976295	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9959944	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-42868	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-43779	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36744722	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-153976295	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10003723	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10699389	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-10010008	usd
CY2022Q1	evex	Increase Decrease Through Net Transfer From Parent Equity IncreaseDecreaseThroughNetTransferFromParentEquity	732776	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	746537	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-107221565	usd
CY2022Q2	evex	Increase Decrease Through Reclassification Of Public Warrants From Liability IncreaseDecreaseThroughReclassificationOfPublicWarrantsFromLiability	10580000	usd
CY2022Q2	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	87352000	usd
CY2022Q2	evex	Stock Issued During Period Value Reverse Recapitalization Net Of Fees StockIssuedDuringPeriodValueReverseRecapitalizationNetOfFees	315326717	usd
CY2022Q2	evex	Stock Issued During Period Value Restricted Stock Units And Restricted Stock Units Expense StockIssuedDuringPeriodValueRestrictedStockUnitsAndRestrictedStockUnitsExpense	1935988	usd
CY2022Q2	evex	Stock Issued During Period Value Exercise Of Warrants Held By Private Investment In Public Equity Investor StockIssuedDuringPeriodValueExerciseOfWarrantsHeldByPrivateInvestmentInPublicEquityInvestor	8000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1028182	usd
CY2022Q2	evex	Decrease Increase Through Net Distributions To Parent Equity DecreaseIncreaseThroughNetDistributionsToParentEquity	2105409	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	307650450	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-36744722	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15000000	usd
CY2022Q3	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	17424230	usd
CY2022Q3	evex	Stock Issued During Period Value Restricted Stock Units And Restricted Stock Units Expense StockIssuedDuringPeriodValueRestrictedStockUnitsAndRestrictedStockUnitsExpense	653699	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	691909	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	304675566	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1013853	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-2509424	usd
CY2021Q1	evex	Increase Decrease Through Net Transfer From Parent Equity IncreaseDecreaseThroughNetTransferFromParentEquity	3004907	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-569476	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	50195	usd
CY2021Q2	evex	Increase Decrease Through Net Transfer From Parent Equity IncreaseDecreaseThroughNetTransferFromParentEquity	2283398	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-1927301	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3759102	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-42868	usd
CY2021Q3	evex	Increase Decrease Through Net Transfer From Parent Equity IncreaseDecreaseThroughNetTransferFromParentEquity	19606615	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	13877344	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	65835	usd
	evex	Long Term Incentive Plan Expense Income LongTermIncentivePlanExpenseIncome	111731	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2589688	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	100368821	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	evex	Interest Income On Financial Investments InterestIncomeOnFinancialInvestments	1992194	usd
	evex	Interest Income On Financial Investments InterestIncomeOnFinancialInvestments	0	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3291352	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2983021	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-205159	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	0	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2803599	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-586231	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	4641968	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	4971910	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3538438	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	921084	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38719982	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7458636	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	169000000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
	evex	Payments To Fund Short Term Loans To Related Parties PaymentsToFundShortTermLoansToRelatedParties	81000000	usd
	evex	Payments To Fund Short Term Loans To Related Parties PaymentsToFundShortTermLoansToRelatedParties	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	418721	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-250418721	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	7104583	usd
	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	369830250	usd
	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	15000000	usd
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	15754066	usd
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	1372633	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	352703551	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22104583	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	63564848	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14645947	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14376523	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77941371	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-42868	usd
CY2021Q3	evex	Increase Decrease Through Net Transfer From Parent Equity IncreaseDecreaseThroughNetTransferFromParentEquity	19606615	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	13877344	usd
	us-gaap	Net Income Loss NetIncomeLoss	-153976295	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	65835	usd
	evex	Long Term Incentive Plan Expense Income LongTermIncentivePlanExpenseIncome	-190518	usd
	evex	Long Term Incentive Plan Expense Income LongTermIncentivePlanExpenseIncome	111731	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2589688	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	100368821	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	evex	Interest Income On Financial Investments InterestIncomeOnFinancialInvestments	1992194	usd
	evex	Interest Income On Financial Investments InterestIncomeOnFinancialInvestments	0	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3291352	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2983021	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-205159	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	0	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2803599	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-586231	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	4641968	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	4971910	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3538438	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	921084	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38719982	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7458636	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	169000000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
	evex	Payments To Fund Short Term Loans To Related Parties PaymentsToFundShortTermLoansToRelatedParties	81000000	usd
	evex	Payments To Fund Short Term Loans To Related Parties PaymentsToFundShortTermLoansToRelatedParties	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	418721	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-250418721	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	7104583	usd
	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	369830250	usd
	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	15000000	usd
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	15754066	usd
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	1372633	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	352703551	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22104583	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	63564848	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14645947	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14376523	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77941371	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14645947	usd
	us-gaap	Contribution Of Property ContributionOfProperty	0	usd
	us-gaap	Contribution Of Property ContributionOfProperty	2790336	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	489590	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14645947	usd
	us-gaap	Contribution Of Property ContributionOfProperty	0	usd
	us-gaap	Contribution Of Property ContributionOfProperty	2790336	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	489590	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2805955	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	939106	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3265612	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3745061	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9902030	usd
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-14041	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-57914	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3759102	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9959944	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3759102	usd
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	220000000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	220000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
	us-gaap	Net Income Loss NetIncomeLoss	-9959944	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	65835	usd
	evex	Long Term Incentive Plan Expense Income LongTermIncentivePlanExpenseIncome	111731	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2983021	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-586231	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	4971910	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	921084	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7458636	usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	7104583	usd
	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	15000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22104583	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14645947	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14645947	usd
	us-gaap	Contribution Of Property ContributionOfProperty	2790336	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14376523	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	220000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6274397	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	20870920	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	699753	usd
CY2021Q4	us-gaap	Assets Assets	21570673	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	877641	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2805955	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6636418	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	939106	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3745061	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9902030	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-57914	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3759102	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9959944	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3759102	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9959944	usd
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	220000000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	220000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
	us-gaap	Net Income Loss NetIncomeLoss	-9959944	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	65835	usd
	evex	Long Term Incentive Plan Expense Income LongTermIncentivePlanExpenseIncome	111731	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2983021	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-586231	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	4971910	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	921084	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7458636	usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	7104583	usd
	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	15000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22104583	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14645947	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14645947	usd
	us-gaap	Contribution Of Property ContributionOfProperty	2790336	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14376523	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	220000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6274397	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	20870920	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	699753	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	877641	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	8642340	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	32226	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	616156	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10168363	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	702921	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10871284	usd
CY2021Q4	evex	Net Parent Investment NetParentInvestment	10731615	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32226	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	8642340	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	32226	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	616156	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10168363	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	702921	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10871284	usd
CY2021Q4	evex	Net Parent Investment NetParentInvestment	10731615	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32226	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10699389	usd
	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-7909182	usd
	evex	Transaction Cost Incurred TransactionCostIncurred	24300000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; line-height: inherit;">Use of Estimates </span></p> <p style="margin: 8pt 0pt 0pt; text-indent: 22.5pt; line-height: 1.2; font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><span style="font-size: 10pt; font-family: 'times new roman', times; line-height: inherit;">The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires the Company’s management to make estimates and judgments that affected the reported amounts of assets and liabilities and allocations of expenses. These judgments were based on the historical experience, management’s evaluation of trends in the industry and other factors that were deemed relevant at that time. The estimates and assumptions were reviewed on a regular basis and the changes to accounting estimates were recognized in the period in which the estimates were revised. The Company’s management recognize that the actual results could be materially different from the estimates. Until December 31, 2021, under the management approach, the s</span><span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif; margin: 8pt 0pt; text-align: justify; text-indent: 20pt;"><span style="font-size: 10pt; font-family: 'times new roman', times; line-height: inherit;">ignificant estimates inherent in the preparation of the unaudited condensed consolidated financial statements include, but are not limited to, useful lives of capitalized software, net, accrued liabilities, income taxes including deferred tax assets and liabilities. Under the legal entity approach, the significant estimates include, </span></span><span style="font-size: 10.0pt; mso-ansi-language: EN-US;">but are not limited to the New Warrants measurement, the allocation of expenses paid ERJ and EAH, fair value measurement and income taxes. </span></p>
	us-gaap	Derivatives Methods Of Accounting Hedge Documentation DerivativesMethodsOfAccountingHedgeDocumentation	<p style="font-size: 10pt; line-height: 1.2; margin: 0px; text-align: justify; text-indent: 0px;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; line-height: inherit;">Hedge accounting</span></p> <p style="line-height: 10pt; text-align: justify; text-indent: 0px; margin: 0px;"><br/></p> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">Until December 31, 2021, the Company accounted for certain derivative instruments under the cash flow hedge accounting methodology to hedge against the payroll cash flow volatility attributable to a risk of foreign exchange rate fluctuation associated with highly probable forecast transactions that will affect income or loss for the year. Effective January 1, 2022, no hedge transactions were observed since the derivative contracts were not transferred to Eve. </span></p> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. For derivatives designated in hedging relationships changes in the fair value are recognized in Accumulated Other Comprehensive Loss (“AOCI”), to the extent the derivative is effective at offsetting the changes in cash flows being hedged until the hedged item affects earnings. The cash flow impact of the derivative instruments is included in our combined statement of cash flows in net cash used in operating activities. </span></p> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">The Company only enters into derivative contracts that it intends to designate as a hedge of a forecasted transaction or the variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). For all hedging relationships, Eve formally documents the hedging relationship and its risk-management objective and strategy for undertaking the hedge, the hedging instrument, the hedged transaction, the nature of the risk being hedged, how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness. The Company also formally assesses, both at the inception of the hedging relationship and on an ongoing basis, whether the derivatives that are used in hedging relationships are highly effective in offsetting changes in cash flows of hedged transactions. For derivative instruments that are designated and qualify as part of a cash flow hedging relationship, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive loss and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. </span></p> <div> <div id="t_ft_46FRHKFJY800000000000000000000b"> </div> </div> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">Eve discontinues hedge accounting prospectively when it determines that the derivative is no longer effective in offsetting cash flows attributable to the hedged risk, the derivative expires or is sold, terminated, or exercised, the cash flow hedge is designated because a forecasted transaction is not probable of occurring, or management determines to remove the designation of the cash flow hedge. Additionally, when it is probable that a forecasted transaction will not occur, Eve recognizes immediately in earnings gains and losses that were accumulated in other comprehensive loss related to the hedging relationship.</span></p> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">In all situations in which hedge accounting is discontinued and the derivative remains outstanding, Eve</span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> continues to carry the derivative at its fair value on the balance sheet and recognizes any subsequent changes in its fair value in earnings.</span></p>
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	418721	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10699389	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21570673	usd
	evex	Transaction Cost Incurred Which Related To Merger Activity TransactionCostIncurredWhichRelatedToMergerActivity	21400000	usd
	evex	Transaction Cost Capitalized TransactionCostCapitalized	15700000	usd
	evex	Transaction Cost Recognized As Expense Related To Merger Activity TransactionCostRecognizedAsExpenseRelatedToMergerActivity	5700000	usd
CY2021Q3	evex	Transaction Cost Incurred Which Related To Merger Activity TransactionCostIncurredWhichRelatedToMergerActivity	70000.00	usd
	evex	Transaction Cost Incurred Which Related To Merger Activity TransactionCostIncurredWhichRelatedToMergerActivity	500000	usd
	evex	Transaction Cost Incurred Which Related To Carve Out Preparation TransactionCostIncurredWhichRelatedToCarveOutPreparation	2400000	usd
	evex	Transaction Cost Incurred Which Related To Carve Out Preparation Prior Fiscal Period TransactionCostIncurredWhichRelatedToCarveOutPreparationPriorFiscalPeriod	1900000	usd
	evex	Transaction Cost Incurred Which Related To Carve Out Preparation Current Fiscal Period TransactionCostIncurredWhichRelatedToCarveOutPreparationCurrentFiscalPeriod	500000	usd
	evex	Transaction Cost Incurred Which Related To Impact To Statement Of Operations TransactionCostIncurredWhichRelatedToImpactToStatementOfOperations	8600000	usd
	evex	Transaction Cost Incurred TransactionCostIncurred	2000000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; line-height: inherit;">Use of Estimates </span></p> <p style="margin: 8pt 0pt 0pt; text-indent: 22.5pt; line-height: 1.2; font-size: 10pt; font-family: 'Times New Roman'; text-align: justify;"><span style="font-size: 10pt; font-family: 'times new roman', times; line-height: inherit;">The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires the Company’s management to make estimates and judgments that affected the reported amounts of assets and liabilities and allocations of expenses. These judgments were based on the historical experience, management’s evaluation of trends in the industry and other factors that were deemed relevant at that time. The estimates and assumptions were reviewed on a regular basis and the changes to accounting estimates were recognized in the period in which the estimates were revised. The Company’s management recognize that the actual results could be materially different from the estimates. Until December 31, 2021, under the management approach, the s</span><span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif; margin: 8pt 0pt; text-align: justify; text-indent: 20pt;"><span style="font-size: 10pt; font-family: 'times new roman', times; line-height: inherit;">ignificant estimates inherent in the preparation of the unaudited condensed consolidated financial statements include, but are not limited to, useful lives of capitalized software, net, accrued liabilities, income taxes including deferred tax assets and liabilities. Under the legal entity approach, the significant estimates include, </span></span><span style="font-size: 10.0pt; mso-ansi-language: EN-US;">but are not limited to the New Warrants measurement, the allocation of expenses paid ERJ and EAH, fair value measurement and income taxes. </span></p>
	us-gaap	Derivatives Methods Of Accounting Hedge Documentation DerivativesMethodsOfAccountingHedgeDocumentation	<p style="font-size: 10pt; line-height: 1.2; margin: 0px; text-align: justify; text-indent: 0px;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; line-height: inherit;">Hedge accounting</span></p> <p style="line-height: 10pt; text-align: justify; text-indent: 0px; margin: 0px;"><br/></p> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">Until December 31, 2021, the Company accounted for certain derivative instruments under the cash flow hedge accounting methodology to hedge against the payroll cash flow volatility attributable to a risk of foreign exchange rate fluctuation associated with highly probable forecast transactions that will affect income or loss for the year. Effective January 1, 2022, no hedge transactions were observed since the derivative contracts were not transferred to Eve. </span></p> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. For derivatives designated in hedging relationships changes in the fair value are recognized in Accumulated Other Comprehensive Loss (“AOCI”), to the extent the derivative is effective at offsetting the changes in cash flows being hedged until the hedged item affects earnings. The cash flow impact of the derivative instruments is included in our combined statement of cash flows in net cash used in operating activities. </span></p> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">The Company only enters into derivative contracts that it intends to designate as a hedge of a forecasted transaction or the variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). For all hedging relationships, Eve formally documents the hedging relationship and its risk-management objective and strategy for undertaking the hedge, the hedging instrument, the hedged transaction, the nature of the risk being hedged, how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness. The Company also formally assesses, both at the inception of the hedging relationship and on an ongoing basis, whether the derivatives that are used in hedging relationships are highly effective in offsetting changes in cash flows of hedged transactions. For derivative instruments that are designated and qualify as part of a cash flow hedging relationship, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive loss and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. </span></p> <div> <div id="t_ft_46FRHKFJY800000000000000000000b"> </div> </div> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">Eve discontinues hedge accounting prospectively when it determines that the derivative is no longer effective in offsetting cash flows attributable to the hedged risk, the derivative expires or is sold, terminated, or exercised, the cash flow hedge is designated because a forecasted transaction is not probable of occurring, or management determines to remove the designation of the cash flow hedge. Additionally, when it is probable that a forecasted transaction will not occur, Eve recognizes immediately in earnings gains and losses that were accumulated in other comprehensive loss related to the hedging relationship.</span></p> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">In all situations in which hedge accounting is discontinued and the derivative remains outstanding, Eve</span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> continues to carry the derivative at its fair value on the balance sheet and recognizes any subsequent changes in its fair value in earnings.</span></p>
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2021Q4	evex	Transaction Cost Incurred TransactionCostIncurred	400000	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2022Q3	us-gaap	Prepaid Insurance PrepaidInsurance	2261554	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	0	usd
CY2022Q3	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	583500	usd
	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	greater than 50%
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	pure
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14298925	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2805955	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6636418	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-38568200	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3745061	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9902030	usd
	us-gaap	Derivatives Methods Of Accounting Hedging Derivatives DerivativesMethodsOfAccountingHedgingDerivatives	<p style="margin: 0px; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1; text-indent: 0px;"><span style="font-family: 'times new roman', times; line-height: inherit;"><b style="mso-bidi-font-weight: normal;"><span style="font-size: 10pt; color: black; line-height: inherit;">Derivative Financial Instruments</span></b></span></p> <p style="margin: 0pt; text-align: justify; font-size: 7pt;"><span style="font-family: 'Times New Roman'; font-size: 7pt;"> </span></p> <p style="margin: 0cm 0cm 0.0001pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit; margin: 8pt 0cm; text-align: justify; text-indent: 20pt;"><span style="font-size: 10pt; color: #000000; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: 'times new roman', times; line-height: inherit;"> The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “<i>Derivatives and Hedging</i>”. The Company’s derivative instruments are recorded at fair value and re-valued at each reporting date, with changes in the fair value reported in the Statement of Operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. </span></span></p>
CY2021Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	4077	usd
CY2022Q3	evex	Advances To Employees AdvancesToEmployees	129424	usd
CY2021Q4	evex	Advances To Employees AdvancesToEmployees	17063	usd
CY2022Q3	evex	Deferred Transaction Costs Net Current DeferredTransactionCostsNetCurrent	0	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6274397	usd
	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	greater than 50%
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	pure
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14298925	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2805955	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33830890	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6636418	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-38568200	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3745061	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-162499131	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9902030	usd
	us-gaap	Derivatives Methods Of Accounting Hedging Derivatives DerivativesMethodsOfAccountingHedgingDerivatives	<p style="margin: 0px; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1; text-indent: 0px;"><span style="font-family: 'times new roman', times; line-height: inherit;"><b style="mso-bidi-font-weight: normal;"><span style="font-size: 10pt; color: black; line-height: inherit;">Derivative Financial Instruments</span></b></span></p> <p style="margin: 0pt; text-align: justify; font-size: 7pt;"><span style="font-family: 'Times New Roman'; font-size: 7pt;"> </span></p> <p style="margin: 0cm 0cm 0.0001pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit; margin: 8pt 0cm; text-align: justify; text-indent: 20pt;"><span style="font-size: 10pt; color: #000000; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: 'times new roman', times; line-height: inherit;"> The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “<i>Derivatives and Hedging</i>”. The Company’s derivative instruments are recorded at fair value and re-valued at each reporting date, with changes in the fair value reported in the Statement of Operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. </span></span></p>
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	23443	usd
CY2021Q1	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	83164	usd
CY2021Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	106607	usd
CY2021Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	95269	usd
CY2022Q3	us-gaap	Cash Cash	76317314	usd
CY2021Q4	us-gaap	Cash Cash	14131396	usd
CY2022Q3	evex	Private Securities At Carrying Value PrivateSecuritiesAtCarryingValue	1624057	usd
CY2021Q4	evex	Private Securities At Carrying Value PrivateSecuritiesAtCarryingValue	245127	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77941371	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14376523	usd
	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-1624245	usd
	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-7909182	usd
CY2022Q3	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-338523	usd
CY2021Q3	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-3321308	usd
CY2021Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	201876	usd
CY2021Q3	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2546068	usd
CY2021Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2747944	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	699753	usd
	us-gaap	Capitalized Computer Software Period Increase Decrease CapitalizedComputerSoftwarePeriodIncreaseDecrease	-699753	usd
CY2022Q3	us-gaap	Cash Cash	76317314	usd
CY2021Q4	us-gaap	Cash Cash	14131396	usd
CY2022Q3	evex	Private Securities At Carrying Value PrivateSecuritiesAtCarryingValue	1624057	usd
CY2021Q4	evex	Private Securities At Carrying Value PrivateSecuritiesAtCarryingValue	245127	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77941371	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14376523	usd
	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-1624245	usd
	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-7909182	usd
CY2022Q3	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-338523	usd
CY2021Q3	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-3321308	usd
CY2022Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0	usd
CY2022Q3	evex	Provision For Profit Sharing Program ProvisionForProfitSharingProgram	1107702	usd
CY2022Q3	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-338523	usd
CY2021Q3	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-3321308	usd
	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-1624245	usd
	evex	Transaction Cost Recognized As Expense Related To Carve Out Preparation TransactionCostRecognizedAsExpenseRelatedToCarveOutPreparation	6200000	usd
CY2022Q3	evex	Transaction Cost Recognized As Expense Excluding Carve Out Preparation And Merger Activity TransactionCostRecognizedAsExpenseExcludingCarveOutPreparationAndMergerActivity	0	usd
CY2021Q3	evex	Transaction Cost Recognized As Expense Excluding Carve Out Preparation And Merger Activity TransactionCostRecognizedAsExpenseExcludingCarveOutPreparationAndMergerActivity	400000	usd
CY2022Q3	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	14394340	usd
CY2022Q3	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	11829785	usd
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	35263146	usd
CY2022Q3	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	14394340	usd
CY2022Q3	us-gaap	Due From Related Parties DueFromRelatedParties	81843504	usd
CY2022Q3	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	14394340	usd
CY2021Q4	us-gaap	Due From Related Parties DueFromRelatedParties	220000	usd
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8642340	usd
CY2022Q3	evex	Operating Income Loss Net From Transactions With Related Party OperatingIncomeLossNetFromTransactionsWithRelatedParty	11829785	usd
CY2021Q3	evex	Operating Income Loss Net From Transactions With Related Party OperatingIncomeLossNetFromTransactionsWithRelatedParty	423752	usd
CY2021Q4	evex	Provision For Profit Sharing Program ProvisionForProfitSharingProgram	59855	usd
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	860717	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	455392	usd
CY2022Q3	evex	Advances From Customers Current AdvancesFromCustomersCurrent	710000	usd
CY2022Q3	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-338523	usd
CY2021Q3	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-3321308	usd
	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-1624245	usd
	evex	Allocated Corporate Costs Income Net From Transactions With Related Party AllocatedCorporateCostsIncomeNetFromTransactionsWithRelatedParty	-7909182	usd
	evex	Transaction Cost Incurred TransactionCostIncurred	24300000	usd
	evex	Transaction Cost Incurred Which Related To Merger Activity TransactionCostIncurredWhichRelatedToMergerActivity	21400000	usd
	evex	Transaction Cost Capitalized TransactionCostCapitalized	15700000	usd
	evex	Transaction Cost Recognized As Expense Related To Merger Activity TransactionCostRecognizedAsExpenseRelatedToMergerActivity	5700000	usd
CY2021Q3	evex	Transaction Cost Incurred Which Related To Merger Activity TransactionCostIncurredWhichRelatedToMergerActivity	70000.00	usd
	evex	Transaction Cost Incurred Which Related To Merger Activity TransactionCostIncurredWhichRelatedToMergerActivity	500000	usd
	evex	Transaction Cost Incurred Which Related To Carve Out Preparation TransactionCostIncurredWhichRelatedToCarveOutPreparation	2400000	usd
	evex	Transaction Cost Incurred Which Related To Carve Out Preparation Prior Fiscal Period TransactionCostIncurredWhichRelatedToCarveOutPreparationPriorFiscalPeriod	1900000	usd
	evex	Transaction Cost Incurred Which Related To Carve Out Preparation Current Fiscal Period TransactionCostIncurredWhichRelatedToCarveOutPreparationCurrentFiscalPeriod	500000	usd
	evex	Transaction Cost Incurred Which Related To Impact To Statement Of Operations TransactionCostIncurredWhichRelatedToImpactToStatementOfOperations	8600000	usd
	evex	Transaction Cost Incurred TransactionCostIncurred	2000000	usd
CY2021Q4	evex	Transaction Cost Incurred TransactionCostIncurred	400000	usd
	evex	Transaction Cost Recognized As Expense Related To Carve Out Preparation TransactionCostRecognizedAsExpenseRelatedToCarveOutPreparation	6200000	usd
CY2022Q3	evex	Transaction Cost Recognized As Expense Excluding Carve Out Preparation And Merger Activity TransactionCostRecognizedAsExpenseExcludingCarveOutPreparationAndMergerActivity	0	usd
CY2021Q3	evex	Transaction Cost Recognized As Expense Excluding Carve Out Preparation And Merger Activity TransactionCostRecognizedAsExpenseExcludingCarveOutPreparationAndMergerActivity	400000	usd
CY2022Q3	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	14394340	usd
CY2022Q3	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	11829785	usd
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	35263146	usd
CY2022Q3	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	14394340	usd
CY2022Q3	us-gaap	Due From Related Parties DueFromRelatedParties	81843504	usd
CY2022Q3	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	14394340	usd
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8642340	usd
CY2022Q3	evex	Operating Income Loss Net From Transactions With Related Party OperatingIncomeLossNetFromTransactionsWithRelatedParty	11829785	usd
CY2021Q3	evex	Operating Income Loss Net From Transactions With Related Party OperatingIncomeLossNetFromTransactionsWithRelatedParty	423752	usd
	evex	Operating Income Loss Net From Transactions With Related Party OperatingIncomeLossNetFromTransactionsWithRelatedParty	35263146	usd
	evex	Operating Income Loss Net From Transactions With Related Party OperatingIncomeLossNetFromTransactionsWithRelatedParty	1992848	usd
CY2021Q4	evex	Advances From Customers Current AdvancesFromCustomersCurrent	405000	usd
CY2022Q3	evex	Advanced Payments Related To Service Arrangements AdvancedPaymentsRelatedToServiceArrangements	672923	usd
CY2021Q4	evex	Advanced Payments Related To Service Arrangements AdvancedPaymentsRelatedToServiceArrangements	52405	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	418721	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2022Q3	us-gaap	Prepaid Insurance PrepaidInsurance	2261554	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	0	usd
CY2022Q3	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	583500	usd
CY2021Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	4077	usd
CY2021Q4	evex	Advances To Employees AdvancesToEmployees	17063	usd
CY2022Q3	evex	Deferred Transaction Costs Net Current DeferredTransactionCostsNetCurrent	0	usd
CY2021Q4	evex	Deferred Transaction Costs Net Current DeferredTransactionCostsNetCurrent	6253257	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	2974478	usd
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	23443	usd
CY2021Q1	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	83164	usd
CY2021Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	106607	usd
CY2021Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	95269	usd
CY2021Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	201876	usd
CY2021Q3	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2546068	usd
CY2021Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2747944	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	699753	usd
	us-gaap	Capitalized Computer Software Period Increase Decrease CapitalizedComputerSoftwarePeriodIncreaseDecrease	-699753	usd
CY2022Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0	usd
CY2022Q3	evex	Provision For Profit Sharing Program ProvisionForProfitSharingProgram	1107702	usd
CY2021Q4	evex	Provision For Profit Sharing Program ProvisionForProfitSharingProgram	59855	usd
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	860717	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	455392	usd
CY2022Q3	evex	Advances From Customers Current AdvancesFromCustomersCurrent	710000	usd
CY2022Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	599785	usd
CY2021Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2022Q3	evex	Social Charges Payable Current SocialChargesPayableCurrent	417632	usd
CY2021Q4	evex	Social Charges Payable Current SocialChargesPayableCurrent	163384	usd
CY2022Q3	evex	Long Term Incentive Plan LongTermIncentivePlan	147951	usd
CY2021Q4	evex	Long Term Incentive Plan LongTermIncentivePlan	183041	usd
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	1319077	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3677865	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	616156	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	838845	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	266371485	shares
CY2022Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	599785	usd
CY2021Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2022Q3	evex	Social Charges Payable Current SocialChargesPayableCurrent	417632	usd
CY2021Q4	evex	Social Charges Payable Current SocialChargesPayableCurrent	163384	usd
CY2022Q3	evex	Long Term Incentive Plan LongTermIncentivePlan	147951	usd
CY2021Q4	evex	Long Term Incentive Plan LongTermIncentivePlan	183041	usd
CY2022Q3	us-gaap	Other Liabilities OtherLiabilities	4516710	usd
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	1319077	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3677865	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	616156	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	838845	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	702921	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	266371485	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	266371485	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	220000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	220000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one vote per share
	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	9100000	shares
CY2021Q4	us-gaap	Derivative Instruments In Hedges Assets At Fair Value DerivativeInstrumentsInHedgesAssetsAtFairValue	32226	usd
CY2022Q3	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	0	usd
CY2021Q3	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	0	usd
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	0	usd
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	0	usd
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	220000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	220000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one vote per share
	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	9100000	shares
CY2021Q4	us-gaap	Derivative Instruments In Hedges Assets At Fair Value DerivativeInstrumentsInHedgesAssetsAtFairValue	32226	usd
CY2022Q3	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	0	usd
CY2021Q3	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	0	usd
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	0	usd
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	0	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.014	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.004	pure
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	620084	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-36744722	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3759102	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9959944	usd
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	247010044	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	247010044	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	220000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14172536	shares
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.004	pure
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	620084	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-36744722	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3759102	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9959944	usd
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	272040343	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	220000000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	247010044	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	220000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	220000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14172536	shares
CY2021Q3	us-gaap	Number Of Properties Subject To Ground Leases NumberOfPropertiesSubjectToGroundLeases	2	number
	evex	Percentage Of Federal And State Net Tax Benefits For Payment Upon Agreement PercentageOfFederalAndStateNetTaxBenefitsForPaymentUponAgreement	0.75	pure
CY2021Q3	us-gaap	Number Of Properties Subject To Ground Leases NumberOfPropertiesSubjectToGroundLeases	2	number
	evex	Percentage Of Federal And State Net Tax Benefits For Payment Upon Agreement PercentageOfFederalAndStateNetTaxBenefitsForPaymentUponAgreement	0.75	pure
	evex	Percentage Of Federal And State Net Tax Benefits For Payment Upon Agreement PercentageOfFederalAndStateNetTaxBenefitsForPaymentUponAgreement	0.75	pure

Files In Submission

Name	View Source	Status
0001554855-22-000729-index-headers.html	Edgar Link	pending
0001554855-22-000729-index.html	Edgar Link	pending
0001554855-22-000729.txt	Edgar Link	pending
0001554855-22-000729-xbrl.zip	Edgar Link	pending
evex-20220930.htm	Edgar Link	pending
evex-20220930.xsd	Edgar Link	pending
evex-20220930_cal.xml	Edgar Link	unprocessable
evex-20220930_def.xml	Edgar Link	unprocessable
evex-20220930_htm.xml	Edgar Link	completed
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex313_3.htm	Edgar Link	pending
ex321_4.htm	Edgar Link	pending
ex322_5.htm	Edgar Link	pending
ex323_6.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
evex-20220930_lab.xml	Edgar Link	unprocessable
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
evex-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EVEX
Eve Holding, Inc. Stock $evex

2022 Q4 Form 10-Q Financial Statement

#000155485522000729 Filed on December 23, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVEX Eve Holding, Inc. Stock $evex

2022 Q4 Form 10-Q Financial Statement

#000155485522000729 Filed on December 23, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVEX
Eve Holding, Inc. Stock $evex